Featured Stories
Implantable Pressure Sensor Powered By Musical Frequencies Real-time Neuronal Activity Highlighted by New Fluorescent Dye Manganese May Provide the First Known Treatment for Shiga Toxin
 
Implantable Pressure Sensor Powered By Musical Frequencies

Implantable Pressure Sensor Powered By Musical Frequencies

Scientists at Purdue University have designed a novel in-vivo pressure sensor which generates power by absorbing low frequency sounds, such as the bass frequencies of most music. The sensor consists of an ultra-sensitive cantilever which vibrates at certain frequencies, generating an electric charge. This charge is stored within a capacitor until the vibrations stop, at [...]

Real-time Neuronal Activity Highlighted by New Fluorescent Dye

Real-time Neuronal Activity Highlighted by New Fluorescent Dye

In order to monitor and decipher the interactions of brain cells, or neurons, scientists have resorted to a variety of methods including gold nanoparticle arrays, complex neurochips and simple cation-sensitive dyes. Researchers at the Tsien lab at the University of California, San Diego School of Medicine, however, have developed a new fast-acting fluorescent dye that improves upon [...]

Manganese May Provide the First Known Treatment for Shiga Toxin

Manganese May Provide the First Known Treatment for Shiga Toxin

Shiga toxin is a dangerous by-product of certain infectious bacteria, such as strains of Shigella and E. coli, which causes symptoms ranging from intestinal pain to kidney failure and even death. Over 150 million people are afflicted with Shiga toxicosis every year, mostly in developing countries where waterborne diseases are prevalent. It is estimated that [...]

New Blood Test Predicts Effectiveness of Antidepressants

New Blood Test Predicts Effectiveness of Antidepressants

16 December 2011

Depression has become increasingly prevalent in today’s society, affecting a staggering 35 million Americans at some point in their lifetime (about 16% of the population). Research has shown that 60% of patients do not receive proper treatment, while 60% of treated patients do not respond to their first trial of antidepressants. Researchers at Layola University [...]

Read the full story

Posted in Bio News0 Comments

Home Health Monitoring Sent to the Cloud Via Qualcomm Life’s 2net Hub

Home Health Monitoring Sent to the Cloud Via Qualcomm Life’s 2net Hub

13 December 2011

Qualcomm Life, a subdivision of the major telecom product company that aspires to be a market leader in the developing wireless health network, recently unveiled their new 2net™ Platform and Hub.  Qualcomm Life was formed last week as a wholly owned subsidiary to operate the formerly known Qualcomm Wireless Health. 2net™ includes a wireless hub [...]

Read the full story

Posted in Bio Business News, Bio Companies, Bio News, Bio Products News1 Comment

Further Evidence Suggests Aspirin Reduces Cancer Risk

Further Evidence Suggests Aspirin Reduces Cancer Risk

09 December 2011

Cancer can be caused by a complex cascade of events, one of which is believed to be chronic inflammation. Inflammation is the body’s immune response to the presence of foreign particles such as pathogens or irritants, and is designed to remove such particles. Immune cells are called to the site of inflammation to envelop foreign [...]

Read the full story

Posted in Bio News0 Comments

Researchers Discover Early Signatures in Prion Diseases like Mad Cow Disease

Researchers Discover Early Signatures in Prion Diseases like Mad Cow Disease

02 December 2011

As published earlier this month in the peer-reviewed journal Public Library of Science (PLoS) Pathogens, researchers have discovered that fatal prion diseases such as Bovine spongiform encephalopathy (a.k.a. Mad Cow Disease) show signs of destroying a particular protein up to seven months prior to infection. This protein called shadoo is found in lower concentrations as [...]

Read the full story

Posted in Bio Education, Bio News, Bio Research News0 Comments

Gene Therapy For Parkinson’s Completes Phase II Trials

Gene Therapy For Parkinson’s Completes Phase II Trials

02 December 2011

Parkinson’s is caused primarily by the degeneration of dopamine producing neurons in the brain, which results in loss of motor and speech control, imbalance, and cognitive disfunction. Recently it has been found that these symptoms are only indirectly caused by low dopamine levels. In reality, the degeneration of dopamine neurons prevents transmittance of the inhibitory [...]

Read the full story

Posted in Bio News0 Comments

Using Genetically Modified Zebrafish to Model Atherosclerosis

Using Genetically Modified Zebrafish to Model Atherosclerosis

25 November 2011

Researchers at the University of California San Diego School of Medicine, in collaboration with Australian colleagues, have genetically modified zebrafish to serve as a model for atherosclerosis, a disorder where arterial walls are hardened from the buildup of LDL (or bad cholesterol) and other substances that form rigid structures called plaques. Atherosclerosis is a dangerous [...]

Read the full story

Posted in Bio Education, Bio News, Bio Research News0 Comments

Get Email Updates!